| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9153770 | American Heart Journal | 2005 | 8 Pages |
Abstract
LVF assessment improved despite high preintervention rates. Treatment rates with ACE-I and vasodilators remained high, but did not improve. Treatment rates with BB improved substantially translating into a significant public health benefit. Health-care payers should consider development of financial incentives to encourage collaborative quality improvement programs.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
David C. MD, PhD, Mark W. MD, PhD, Alain G. MD, MPH, Jennifer BSPH, Walter T. PhD, Jill RN, BSN, MSPH, Vanessa MS, Carla A. MD, PhD, FACC, Janet B. PhD,